Your drug has passed through the phase I clinical trial and you’ve selected and contacted the sites you want to work with. Now it’s time to get your trial up and running in the EU. What do you do? Let’s walk through the process step by step. At Siron Clinical, we...
As a CRO, we talk about clinical research and clinical trials, but what’s the difference? Can the two terms be used interchangeably? And why does it matter? Every treatment on the market is the result of years of research – not just studies involving the treatment...
How does the Siron Clinical team ensure the success of our clients’ clinical trials around the world? Let’s take a look behind the scenes at people’s roles and how they work together. When Jan Balemans, Founder and CEO of Siron Clinical, started the company in 2000,...
At Siron Clinical, we are proud of our specialized therapeutic expertise in tackling complex clinical trials. Over the last 20 years, we have worked on 120 trials including orphan indications, pediatric, cardiovascular, oncology, hepatology and dermatology studies....